Sci-tech

We Finally Have A Release Date For Xenoblade Chronicles 2

We Finally Have A Release Date For Xenoblade Chronicles 2”

But there's good reason to believe the game will make its release, as the previous two games in the series also released in December. Along with that, it will be packing full English voice acting (for anyone interested in that). That will be capped when Xenoblade Chronicles 2 hits the system later this year on December 1; just in time for Christmas as was announced at today's Nintendo Direct. Hopefully this can live up to fan hype, because an epic RPG like this on the go would be great.

Nintendo also posted what the game is about: "Take a closer look at Xenoblade Chronicles 2 with Azurda, a Titan! You can form powerful bonds with Blades, unique beings granting tremendous power to their users, called Drivers".

Xenoblade Chronicles 2 Releasing This December

Video game stories from other sites on the web.

The pro controller follows the first game's special Monado Red Wii Classic Controller that came in European bundles, though you'll need to purchase it separately from the game.



Like this

Latest


14 September 2017
Hartlepool council boss welcomes scrapping of public sector pay cap
A national rally will be held in Westminster in October and the TUC is planning a meeting with the Chancellor. Unison general secretary Dave Prentis said: "It's a tiny step in the right direction but not almost enough".

14 September 2017
Try the gorgeous RPG 'Project Octopath Traveler' tonight on Switch
Following the demo, Nintendo will roll out a survey to gather player feedback so developers can further fine-tune the game. There are eight playable characters in Project Octopath Traveler , each with unique abilities and backstories.

14 September 2017
BlizzCon 2017 Virtual Tickets are are coming back this year
Check out the Blizzcon 2017 Virtual Ticket page for more information. "BlizzCon is a huge community event for us". You can check out our Blizzcon 2017 goody bag unboxing to check out what's inside.

14 September 2017
CPM expels RS member for anti-party acts
CPI (M) had formed a three-member inquiry committee headed by party's Lok Sabha MP Md Salim which submitted its report last month. There are reports that Banerjee, who is known for his articulation in Rajya Sabha, has been approached by both Trinamool and BJP.

14 September 2017
Australian ex-PM's godson attacked while campaigning for same-sex marriage
The managing director of the ACL says homophobia isn't a problem in Australia. When the man asked if Foster was calling him a homophobe, he replied yes.

14 September 2017
Privacy improvements in Windows 10 Fall Creators Update — Microsoft
With two factor unlock, an enterprise can enforce an additional security layer to their sensitive data via an MDM policy. Be sure to stay tuned for more! Despite the complaints, Microsoft did not acknowledge these issues until now.

14 September 2017
CenturyLink Target of Unusually High Options Trading (NYSE:CTL)
The technology company reported $0.46 earnings per share for the quarter, missing analysts' consensus estimates of $0.49 by $0.03. Their average price target spell out an upbeat performance - a 40% and would give CTL a market capitalization of almost $14.38B.

14 September 2017
Cubs look to get well vs. struggling Mets
Nobody is talking about it here. "It was a really good night for us", he said. "This win was really important for us". I like the fact that it's hard right now, and I think that we should learn something about ourselves going forward.

14 September 2017
National Football League suspends Texans LB Brian Cushing 10 games
He will be eligible to return to the roster on November 28, after the team's game against the Baltimore Ravens . It's a significant blow to a Houston team that was routed by the Jacksonville Jaguars in Week 1.

14 September 2017
Teva Pharmaceutical Industries Limited (TEVA) Upgraded to Sell by BidaskClub
The company reported $1.38 earnings per share for the quarter, beating the Thomson Reuters' consensus estimate of $1.36 by $0.02. Barclays Capital maintained Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) on Monday, August 7 with "Equal-Weight" rating.



Recommended